GSK purchases Elsie, a firm producing oligonucleotides.
can be manipulated to engineer drugs that change gene expressions. This drug class is now well-established, and companies like GSK are making it a core element in their development plans, alongside typical proteins and pills. GSK is also backing off cell therapies